Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

New investigational drug targeting difficult to treat breast cancers to undergo pan-European phase II clinical trials

New investigational drug targeting difficult to treat breast cancers to undergo pan-European phase II clinical...

ECC 2015: Genetic screening of brain metastases could reveal new targets for treatment

ECC 2015: Genetic screening of brain metastases could reveal new targets for treatment

ECC 2015: Treatment of elderly patients with breast cancer varies between different countries throughout Europe

ECC 2015: Treatment of elderly patients with breast cancer varies between different countries throughout Europe

ECC 2015: Cabozantinib improves survival in patients with advanced kidney cancer: results from the METEOR trial

ECC 2015: Cabozantinib improves survival in patients with advanced kidney cancer: results from the METEOR trial

ECC 2015: Nivolumab improves overall survival in patients with advanced kidney cancer: results from the CheckMate 025 trial

ECC 2015: Nivolumab improves overall survival in patients with advanced kidney cancer: results from the CheckMate...

Linking cancer with rare disease

Linking cancer with rare disease

ECC 2015: Discovery of significant genetic differences between breast cancers that relapse and those that do not will lead to better treatment

ECC 2015: Discovery of significant genetic differences between breast cancers that relapse and those that do not...

3D printing opens the possibility for bespoke cancer therapy

3D printing opens the possibility for bespoke cancer therapy

Modernising clinical trials for the benefit of Europe’s patients

Modernising clinical trials for the benefit of Europe’s patients

Digital 'Rosetta Stone' decrypts how mutations rewire cancer cells

Digital 'Rosetta Stone' decrypts how mutations rewire cancer cells

More from ecancer